Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

4.27USD
1 Aug 2014
Price Change (% chg)

$-0.07 (-1.61%)
Prev Close
$4.34
Open
$4.33
Day's High
$4.38
Day's Low
$4.19
Volume
2,507,674
Avg. Vol
--
52-wk High
--
52-wk Low
--

NVAX.O

Chart for NVAX.O

About

Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional... (more)

Overall

Beta: 1.21
Market Cap (Mil.): $1,033.14
Shares Outstanding (Mil.): 238.06
Dividend: --
Yield (%): --

Financials

  NVAX.O Industry Sector
P/E (TTM): -- 102.69 36.20
EPS (TTM): -0.31 -- --
ROI: -37.91 -0.51 18.07
ROE: -41.54 -1.55 18.86
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF79.55 -0.80
Merck & Co., Inc. (MRK.N) $56.80 +0.06
Sanofi SA (SASY.PA) €78.91 +0.29
GlaxoSmithKline plc (GSK.L) 1,416.50p -20.00
AstraZeneca plc (AZN.L) 4,338.50p -6.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks